查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1511894

mRNA合成原料的市場規模、佔有率和趨勢分析報告：按類型、應用、最終用途、地區和細分市場預測，2024-2030年

mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report By Type (Capping Agents, Nucleotides), By Application (Vaccine Production, Therapeutics Production), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

mRNA 合成原料市場的成長與趨勢：

Grand View Research最新報告顯示，到2030年，全球mRNA合成原料市場規模預計將達到19.9億美元。

預計2024年至2030年該市場將以2.85%的複合年成長率擴張。推動市場成長的主要因素包括學術界和工業界對 mRNA 技術興趣的增加、mRNA 疫苗的優越性以及研究經費的增加。此外，預計在預測期內，RNA 技術的治療應用不斷增加將為 mRNA 合成市場的原料提供利潤豐厚的機會。

COVID-19大流行增加了對mRNA合成原料的需求，以開發有效的疫苗來對抗感染疾病。 mRNA 疫苗是預防 COVID-19 的安全有效的方法。此外，與mRNA COVID-19疫苗相關的好處引起了製藥公司的關注，以在全球範圍內快速供應疫苗。例如，美國國家過敏和感染疾病研究所與Moderna, Inc.於2020年3月共同開發了mRNA-1273（NIAID）。因此，在 COVID-19 大流行期間，mRNA 疫苗的使用量顯著增加。

此外，許多主要製藥公司已經開始研究以 mRNA 為基礎的療法，包括諾華、亞力兄、阿斯特捷利康、輝瑞、賽諾菲巴斯德和夏爾。例如，2022年1月，根據輝瑞與Acquitas Therapeutics之間的開發和選擇協議，輝瑞將針對多達10個標靶使用Acquitas的LNP技術來開發mRNA療法和疫苗，並有權選擇許可。因此，製藥和生物技術公司對mRNA合成原料的採用率正在增加，這進一步推動了市場的成長。

此外，由於mRNA轉譯的瞬時性以及外來物質不會整合到細胞基因組中，所得的細胞療法產品比使用更傳統方法獲得的產品具有許多優勢。它的一些優點包括易於在公認的製造程序下製造、減少由於目標和期外效應而導致的細胞毒性，以及易於臨床驗證和監管處理，這包括可以改進的方面。因此，這些優勢預計將增加對 mRNA 療法的需求並進一步推動市場成長。

此外，基於 mRNA 的技術也被證明在治療和預防多種疾病方面非常有前景。過去十年技術和科學研究的突破性進展使 mRNA 成為一種可行的治療選擇，消除了與其使用相關的一些問題，例如半衰期短和免疫抗原性。例如，mRNA 技術的進步可能會帶來更安全、更有效的方法，例如與新的過繼性免疫療法相結合，創建最先進的嵌合體抗原受體 T 細胞。因此，mRNA 技術的進步預計將為市場成長開闢新的途徑。

然而，在研究期間，原料的高成本可能會拖累市場。例如，CleanCap AG等原料的採購價格約佔兩種疫苗生產過程中產生的原物料總成本的45%左右。此外，圍繞核准流程的法律規範一直是生物技術、製藥和醫療技術行業最重要的阻礙因素。中國和印度等新興國家的 mRNA 合成原料市場具有巨大的成長潛力，由於存在龐大的患者基礎，且目前尚無有效的法律規範或指南，因此預計未來幾年將出現成長。受到阻礙。

mRNA合成市場原料報告要點

  • 由於封端技術及其在生物製藥工業和研究中的應用的進步，封端劑細分市場在2023年佔據最大佔有率，為39.17%。
  • 從應用來看，疫苗製造業在全球產業中佔據主導地位，2023年銷售佔有率最大。這是因為與利用以細胞培養為基礎的生產途徑的傳統疫苗相比，mRNA 疫苗的生產速度更快，而傳統疫苗往往容易失敗。
  • 預計北美地區將在 2023 年主導全球產業，佔總收益的最大佔有率，超過 36.77%，並在預測期內以最高的複合年成長率成長。
  • 由於生物製藥在商業性取得了巨大成功以及治療藥物需求的快速成長，生物製藥和製藥公司細分市場在 2023 年以最高的收益佔有率佔據了市場主導地位。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第4章 mRNA 合成原料市場：類型業務分析

  • 類型細分儀表板
  • 全球mRNA合成原料市場：類型變異分析
  • 2018-2030年全球mRNA合成原料市場規模及趨勢分析（依類型）
  • 封端劑
  • 核苷酸
  • 質體DNA
  • 酵素
  • 其他

第5章 mRNA合成原料市場：應用商業分析

  • 使用細分儀表板
  • 全球mRNA合成原料市場：應用變化分析
  • 2018年至2030年全球mRNA合成原料市場規模及趨勢分析（依應用）
  • 治療藥物製造
  • 疫苗生產
  • 其他

第6章 mRNA 合成市場原料：最終用途業務分析

  • 最終用途細分儀表板
  • 全球 mRNA 合成原料市場：最終用途變異分析
  • 2018-2030年全球mRNA合成原料市場規模及趨勢分析（依最終用途）
  • 生物製藥和製藥公司
  • 合約研究官（CRO）和首席行銷長（CMO）
  • 學術/研究機構

第 7 章 mRNA 合成原料市場：按類型、應用和最終用途分類的區域估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模及預測及趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭格局

  • 參與企業
  • 策略規劃
  • 2023 年企業市場分析
  • 參與企業概況
    • F. Hoffmann-La Roche Ltd.
    • Jena Bioscience Gmbh
    • Merck KGaA
    • Yeasen Biotechnology（Shanghai）Co.,Ltd.
    • BOC Sciences
    • Thermo Fisher Scientific, Inc.
    • Maravai Lifesciences
    • New England Biolabs
    • Creative Biogene
    • Hongene
Product Code: GVR-4-68040-022-4

mRNA Synthesis Raw Materials Market Growth & Trends:

The global mRNA synthesis raw materials market size is projected to reach USD 1.99 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 2.85% from 2024 to 2030. The major factors driving the market growth include growing academic and industrial interest in mRNA technology, the advantages of mRNA vaccines, and increasing funding for research. In addition, the increasing therapeutic applications of RNA technology are projected to offer lucrative opportunities for the mRNA synthesis raw materials market during the forecast period.

The COVID-19 pandemic has increased the demand for mRNA synthesis raw materials for developing an efficient vaccine to battle infectious diseases. mRNA vaccines are a safe and efficient method for preventing COVID-19. In addition, the advantages associated with the mRNA COVID-19 vaccines have sparked the attention of pharmaceutical businesses in delivering vaccines swiftly across the globe. For instance, the National Institute of Allergy and Infectious Diseases and Moderna, Inc. mutually developed the mRNA-1273 (NIAID) in March 2020. As a result, the usage of mRNA vaccines increased significantly during the COVID-19 pandemic.

Furthermore, many major pharmaceutical firms have started working on mRNA-based therapeutics, including Novartis, Alexion, AstraZeneca, Pfizer, Sanofi Pasteur, and Shire. For instance, in January 2022, according to a development and option agreement between Pfizer Inc. and Acuitas Therapeutics, Pfizer will have the option to license Acuitas' LNP technology for up to 10 targets for the development of mRNA therapeutics & vaccines. Therefore, the adoption rate of mRNA synthesis raw materials has increased among pharma & biotech companies, which further fuels the market growth.

Moreover, due to the temporary nature of mRNA translation and lack of integration of the foreign material into the cell's genome, the resulting cellular therapeutic product has a number of benefits over the one obtained by a more conventional approach. Some of the advantages include easier production under acceptable manufacturing procedures, reduced cytotoxicity from on-target off-tumor effects, and better clinical validation and regulatory treatment. Thus, such advantages are expected to increase the demand for mRNA therapeutics and further boost market growth.

Additionally, regarding the treatment and prevention of several diseases, mRNA-based technologies have been proven to be incredibly promising. Tremendous advances in technology and scientific study over the past ten years have made mRNA a feasible therapeutic option, eliminating some of the problems with its use, such as its brief half-life and innate immunogenicity. For instance, as mRNA technology advances, its fusion with new adoptive immunotherapies may result in safer and more efficient methods, such as the creation of cutting-edge chimeric antigen receptor T-cells. Therefore, advancements in mRNA technology are projected to open new avenues for market growth.

However, the high cost of raw materials may impede the market during the study period. For instance, the purchase price of raw materials, such as CleanCap AG, accounts for around 45% of the total raw material costs incurred while producing both vaccines. In addition, the regulatory framework pertaining to approval processes has always been the most critical restraining factor in the biotechnology, pharmaceutical, and medical technology industry. The absence of effective regulatory framework/guidelines for the therapeutic sector in developing countries such as China and India, where the mRNA synthesis raw materials market holds great growth potential due to the presence of a large patient base, is anticipated to impede the market growth in the coming years.

mRNA Synthesis Raw Materials Market Report Highlights:

  • The capping agents segment held the largest share of 39.17% in 2023 owing to the advancements in the capping technology and their applications in the biopharma industry and research
  • By application, The vaccine production segment dominated the global industry with the largest revenue share in 2023. This can be attributed to the rapid production of mRNA vaccines compared to the conventional vaccines that utilize cell-culture-based production paths, which are often prone to failure.
  • North America dominated the global industry in 2023 and accounted for the largest share of more than 36.77% of the overall revenue in 2023, and is expected to grow at the highest CAGR over the forecast period.
  • The biopharmaceutical and pharmaceutical companies segment dominated the market with the highest revenue share in 2023, due to the high commercial success of biopharmaceuticals and rapid growth in demand for therapeutics.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End-use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing academic and industrial interest in mRNA technology
      • 3.2.1.2. Advantages of mRNA vaccines
      • 3.2.1.3. Increasing funding for mRNA research
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Nonexistence of effective government regulations for mRNA - based product approvals
      • 3.2.2.2. High cost of mRNA synthesis raw materials
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. mRNA Synthesis Raw Materials Market: Type Business Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Global mRNA Synthesis Raw Materials Market Type Movement Analysis
  • 4.3. Global mRNA Synthesis Raw Materials Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Capping Agents
    • 4.4.1. Global Capping Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Nucleotides
    • 4.5.1. Global Nucleotides Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Plasmid DNA
    • 4.6.1. Global Plasmid DNA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Enzymes
    • 4.7.1. Global Enzymes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.2. Polymerase
      • 4.7.2.1. Global Polymerase Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.3. RNase Inhibitor
      • 4.7.3.1. Global RNase Inhibitor Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.4. DNase
      • 4.7.4.1. Global DNase Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.5. Others
      • 4.7.5.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. mRNA Synthesis Raw Materials Market: Application Business Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global mRNA Synthesis Raw Materials Market Application, Movement Analysis
  • 5.3. Global mRNA Synthesis Raw Materials Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Therapeutics Production
    • 5.4.1. Global Therapeutics Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Vaccine Production
    • 5.5.1. Global Vaccine ProductionMarket Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. mRNA Synthesis Raw Materials Market: End-use Business Analysis

  • 6.1. End-use Segment Dashboard
  • 6.2. Global mRNA Synthesis Raw Materials Market End-use Movement Analysis
  • 6.3. Global mRNA Synthesis Raw Materials Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 6.4. Biopharmaceutical & Pharmaceutical Companies
    • 6.4.1. Global Biopharmaceutical & Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. CROs & CMOs
    • 6.5.1. Global CROs & CMOs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Academic & Research Institutions
    • 6.6.1. Global Academic & Research Institutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. mRNA Synthesis Raw Materials Market: Regional Estimates & Trend Analysis by Type, Application, and End-use

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. North America MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. U.S. MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Canada MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Mexico MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. UK MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Germany MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. France MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Italy MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Spain MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Denmark MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Sweden MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Norway MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Japan MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. China MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. India MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Australia MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Thailand MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. South Korea
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. South Korea MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Brazil MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Argentina MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. South Africa MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Saudi Arabia MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. UAE MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Kuwait MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Participant's Overview
    • 8.4.1. F. Hoffmann - La Roche Ltd.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Jena Bioscience Gmbh
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Merck KGaA
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Yeasen Biotechnology (Shanghai) Co.,Ltd.
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. BOC Sciences
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Thermo Fisher Scientific, Inc.
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Maravai Lifesciences
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. New England Biolabs
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Creative Biogene
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Hongene
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global mRNA synthesis raw materials market, by End - use, 2018 - 2030 (USD Million)
  • Table 6 Global mRNA synthesis raw materials market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 9 North America mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 10 North America mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 11 U.S. mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 12 U.S. mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 13 U.S. mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 14 Canada mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 15 Canada mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 16 Canada mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 17 Europe mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 18 Europe mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 19 Europe mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 20 Europe mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 21 UK mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 22 UK mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 23 UK mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 24 Germany mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 25 Germany mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 26 Germany mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 27 France mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 28 France mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 29 France mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 30 Italy mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 31 Italy mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 32 Italy mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 33 Spain mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 34 Spain mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 35 Spain mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 36 Denmark mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 37 Denmark mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 38 Denmark mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 39 Sweden mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 40 Sweden mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 41 Sweden mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 42 Norway mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 43 Norway mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 44 Norway mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 49 Japan mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 50 Japan mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 51 Japan mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 52 China mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 53 China mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 54 China mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 55 India mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 56 India mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 57 India mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 58 Australia mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 59 Australia mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 60 Australia mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 61 Thailand mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 62 Thailand mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 63 Thailand mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 64 South Korea mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 65 South Korea mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 66 South Korea mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 67 Latin America mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 68 Latin America mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 69 Latin America mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 70 Latin America mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 71 Brazil mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 72 Brazil mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 73 Brazil mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 74 Mexico mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 75 Mexico mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 76 Mexico mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 77 Argentina mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 78 Argentina mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 79 Argentina mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 84 South Africa mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 85 South Africa mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 86 South Africa mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 90 UAE mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 91 UAE mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 92 UAE mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 96 Participant's overview
  • Table 97 Financial performance
  • Table 98 Key companies undergoing expansions
  • Table 99 Key companies undergoing acquisitions
  • Table 100 Key companies undergoing collaborations
  • Table 101 Key companies launching new types
  • Table 102 Key companies undertaking other strategies

List of Figures

  • Fig. 1 mRNA synthesis raw materials market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 mRNA synthesis raw materials market driver analysis
  • Fig. 12 mRNA synthesis raw materials market restraint analysis
  • Fig. 13 mRNA synthesis raw materials market: Porter's analysis
  • Fig. 14 mRNA synthesis raw materials market: PESTEL analysis
  • Fig. 15 mRNA synthesis raw materials market: Type outlook and key takeaways
  • Fig. 16 mRNA synthesis raw materials market: Type market share analysis, 2023 - 2030
  • Fig. 17 Global mRNA synthesis raw materials by capping agents market, 2018 - 2030 (USD Million)
  • Fig. 18 Global mRNA synthesis raw materials by nucleotides market, 2018 - 2030 (USD Million)
  • Fig. 19 Global mRNA synthesis raw materials by plasmid DNA market, 2018 - 2030 (USD Million)
  • Fig. 20 Global mRNA synthesis raw materials by enzymes market, 2018 - 2030 (USD Million)
  • Fig. 21 Global mRNA synthesis raw materials by polymerase market, 2018 - 2030 (USD Million)
  • Fig. 22 Global mRNA synthesis raw materials by RNase inhibitor market, 2018 - 2030 (USD Million)
  • Fig. 23 Global mRNA synthesis raw materials by DNase market, 2018 - 2030 (USD Million)
  • Fig. 24 Global mRNA synthesis raw materials by others market, 2018 - 2030 (USD Million)
  • Fig. 25 Global mRNA synthesis raw materials by others market, 2018 - 2030 (USD Million)
  • Fig. 26 mRNA synthesis raw materials market: Application outlook and key takeaways
  • Fig. 27 mRNA synthesis raw materials market: Application market share analysis, 2023 - 2030
  • Fig. 28 Global mRNA synthesis raw materials by vaccine production market, 2018 - 2030 (USD Million)
  • Fig. 29 Global mRNA synthesis raw materials by therapeutics production market, 2018 - 2030 (USD Million)
  • Fig. 30 Global mRNA synthesis raw materials by others market, 2018 - 2030 (USD Million)
  • Fig. 31 mRNA synthesis raw materials market: End-use outlook and key takeaways
  • Fig. 32 mRNA synthesis raw materials market: End-use market share analysis, 2023 - 2030
  • Fig. 33 Global mRNA synthesis raw materials by biopharmaceutical & pharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 34 Global mRNA synthesis raw materials by CROs & CMOs market, 2018 - 2030 (USD Million)
  • Fig. 35 Global mRNA synthesis raw materials by academic & research institutes market, 2018 - 2030 (USD Million)
  • Fig. 36 Regional marketplace: Key takeaways
  • Fig. 37 North America mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Canada mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
  • Fig. 40 Mexico mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Europe mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 UK mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Germany mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 France mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Italy mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Spain mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Denmark mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Sweden mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Norway mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Asia-Pacific mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Japan mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 China mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 India mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Australia mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Thailand mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 South Korea mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Latin America mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Brazil mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Argentina mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 MEA mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 South Africa mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Saudi Arabia mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 UAE mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Kuwait mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Key company categorization
  • Fig. 66 Company market positioning
  • Fig. 67 Market participant categorization
  • Fig. 68 Strategy framework